Pharma IP strategy is often framed as a binary: win fast or wait out the clock. But Hatch-Waxman and the BPCIA have taught the market something more ruthless: timing is destinydown to the calendar day.
Thats why the 5-year vs. 12-year exclusivity debat…
Branded-generic launches are where pricing bets get madeand where many teams still fly blind.
The window between first notice and market reality is short. Competitors move fast, payers respond quickly, and channel partners dont wait for your internal d…
The Unique Mechanism of Ozempic for Weight Loss: A Comprehensive Guide What is Ozempic? Ozempic, also known as semaglutide,… https://www.Drugchatter.com/chat/37116/what-unique-mechanism-does-ozempic-use-for-weight-loss/
DrugChatter: What unique mechanism does ozempic use for weight loss? Read Post »
The Unique Mechanism of Ozempic for Weight Loss: A Comprehensive Guide What is Ozempic? Ozempic, also known as semaglutide,… https://www.Drugchatter.com/chat/37116/what-unique-mechanism-does-ozempic-use-for-weight-loss/
DrugChatter: What unique mechanism does ozempic use for weight loss? Read Post »
The Unique Mechanism of Ozempic for Weight Loss: A Comprehensive Guide What is Ozempic? Ozempic, also known as semaglutide,… https://www.Drugchatter.com/chat/37116/what-unique-mechanism-does-ozempic-use-for-weight-loss/
DrugChatter: What unique mechanism does ozempic use for weight loss? Read Post »
Patent thickets dont just delay genericsthey redraw the rules of time itself.
When a drugs core patent expires, the public is often told the next chapter is simple: generics arrive, competition increases, prices fall. In reality, many launches unfold…
Most generic drug launches arent delayed by sciencetheyre delayed by a calendar.
In branded pharma, timing is often treated like a footnotean implementation detail, something the legal team and the commercial team figure out later. But the modern compe…
Launch First or Lose: How Generic Drug Timing Decides Long-Term Profit Read Post »
Your 2-year LOE window is a 5-year death march. The real pharmaceutical patent cliff timeline.
The industry keeps getting this wrongand its costing companies time, money, and leverage.
For years, executives have spoken about a neat, two-year runway bet…
Patent thickets arent just a legal nuisancetheyre a market mechanism that quietly delays the moment generics and biosimilars can compete.
Heres the part most people miss: the expiration date you see in headlines is often not the same date that decides …
The Purple Book Was Never Designed to Answer the Question Drugmakers Actually Ask
For anyone trying to assess biosimilar competition, the Purple Book is often the first stop.
It is also where many patent strategies begin to go wrong.
The FDAs Purple Bo…
Biologic Patent Tracking: What to Do When the Purple Book Fails You Read Post »